Clostridium is a gram-positive bacteria that belongs to the Firmicutes phylum. There are multiple species of Clostridium — Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, and Clostridium sordellii, which are responsible for numerous infections. Clostridium tetani is responsible for tetanus, Clostridium botulinum causes botulism, Clostridium perfringes leads to gas gangrene, Clostridium sortellii causes pneumonia, endocarditis, arthritis, peritonitis, and myonecrosis, and Clostridium difficile is responsible for diarrhea.
According to the report, one of the major drivers for this market is Rising prevalence of Clostridium-related diseases. Clostridium difficile infection (CDI) is a major cause of hospital-associated GI illness and creates a huge burden on the healthcare system. It is estimated that patients with CDI put a burden of $3.2 billion annually in the US on the healthcare system. Patients with CDI have a longer stay at the hospital, and CDI has been the major cause of large outbreaks of diseases in hospitals. The new molecular diagnostic stool test will replace the current enzyme immunoassay tests.
The global Clostridium Diagnostics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Clostridium Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Clostridium Diagnostics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Clostridium Diagnostics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Clostridium Diagnostics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott
Beckman Coulter
Olympus
Siemens Healthineers
F. Hoffmann-La Roche
BD
bioMerieux
Chrono-log
Corgenix
Diazyme Laboratories
FUJIREBIO DIAGNOSTICS
Hologic
QIAGEN
Sysmex
Thermo Fisher Scientific
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Clostridium Difficile
Clostridium Perfringens
Clostridium Botulinum
Clostridium Tetani
Clostridium Sordellii
Segment by Application
Hospitals
Independent Laboratories
Physicians' Clinics
Others
Summary:
Get latest Market Research Reports on Clostridium Diagnostics. Industry analysis & Market Report on Clostridium Diagnostics is a syndicated market report, published as Global Clostridium Diagnostics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Clostridium Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.